Notice of Intent to Sole Source - chemiluminescent-based testing reagents compatible with the Abbott Alinity Instrumentation
ID: W81K00-24-P-0154Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/8898ad84ae934749ad1ebcf733347f4c/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Army, intends to procure chemiluminescent microparticle immunoassay (CMIA) reagent kits compatible with the Abbott Alinity Instrumentation for the Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. This procurement aims to establish a cost-per-test arrangement for reagents necessary for conducting tests that detect traumatic brain injury markers, which are critical for timely treatment decisions and improved outcomes for service members and civilians. Abbott Laboratories has been identified as the sole supplier capable of meeting the FDA regulatory requirements and operational needs of the Department of Defense's only Level 1 trauma center, with a total contract value of $491,206.52 for the base year and four option years. Interested parties can contact Medina L. Woodson at medina.l.woodson.civ@health.mil or by phone at 210-539-8525 for further details.

    Point(s) of Contact
    Medina L. Woodson
    (210) 539-8525
    (210) 221-3446
    medina.l.woodson.civ@health.mil
    Files
    Title
    Posted
    FY24_JA Sole Source______________Human Serum PlasmaTesting_Abbott Laboratories_ Redacted.pdf
    The document details a Sole Source Justification and Approval for a contract with Abbott Laboratories to provide human serum/plasma testing services at the Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The procurement focuses on establishing a cost-per-test (CPT) arrangement for the necessary reagents and consumables, crucial for performing chemiluminescent microparticle immunoassay (CMIA) tests to detect traumatic brain injury markers (GFAP and UCH-L1). The total contract value is $491,206.52 for the base year and four option years, with cost escalation due to inflation considered. Abbott Laboratories is identified as the sole supplier capable of meeting the FDA regulatory requirements and the operational needs for the Department of Defense's only Level 1 trauma center. This testing capability will enable BAMC to be a pioneer in improved TBI diagnostics, providing a rapid test that leads to timely treatment decisions and better outcomes for service members and civilians. The document also outlines steps taken to ensure competition in future contracts beyond the current arrangements and provides a thorough market analysis affirming Abbott's unique position in supplying these vital tests.
    Similar Opportunities
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    Q301--Abbott I-Stat Cost Per Test for Creatinine and Troponin Testing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a Firm-Fixed priced contract to Abbott Laboratories, Inc. for the procurement of services related to creatinine and troponin testing at the VA North Texas Health Care System. This contract will cover the cost per test reagent agreement, including the supply of i-STAT instruments, associated services, and necessary supplies, with the stipulation that only Abbott's trained technicians will perform the required services due to the proprietary nature of the equipment. The arrangement is crucial for maintaining operational integrity and ensuring timely patient care, as switching suppliers would not be cost-effective and could disrupt laboratory services at the Dallas VA Medical Center. For further inquiries, interested parties can contact Contract Specialist Joshua Weisman at joshua.weisman@va.gov or (432) 213-7094.
    CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is planning to issue a sole source award contract to Roche Diagnostics Corporation for the Chemistry and Immunoassay Testing Program. This program is intended to sustain the use of three Chemistry and Immunochemistry Systems under a Cost Per Reportable Result (CPRR) agreement or Cost Per Reagent Pack. The program includes equipment, reagents, tools, materials, training, and a water purification system, Uninterruptible Power Supply (UPS), and services necessary to meet the Chemistry and Immunochemistry testing and analysis requirements for Walter Reed National Military Medical Center (WRNMMC) laboratories. The anticipated period of performance is five years.
    Kidney Reagents for Luminex 3D Analyzer
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract for Kidney Reagents for the Luminex 3D Analyzer, specifically for the Kidney Transplant Clinic at The Walter Reed National Military Medical Center in Bethesda, Maryland. The procurement aims to secure molecular and serological reagents from One Lambda Inc. that are essential for transplant testing, ensuring compatibility and reducing the risk of organ rejection between donors and recipients. These reagents are critical as they have been validated by the American Society of Histocompatibility and Immunogenetics (ASHI) and are necessary for maintaining the accreditation of the Immunology Lab. Interested parties may express their interest and provide a capability statement to Barbara Sonnier at barbara.n.sonnier.civ@health.mil by September 24, 2024, at 10:00 PM EST.
    Chemistry and Immunochemistry
    Active
    Veterans Affairs, Department Of
    Special Notice: VETERANS AFFAIRS, DEPARTMENT OF is seeking Chemistry and Immunochemistry services. This procurement is typically used for analytical laboratory testing and research. The contract will be awarded to ABBOTT LABORATORIES on October 1, 2024, and will be in effect until September 30, 2029. The place of performance is Montgomery, Alabama, United States. The contract is a firm-fixed price sole source requirement. For more information, please contact Derrell D Calhoun at Derrell.Calhoun@va.gov or 4782721210.
    6550--VISN Multiplex PCR Testing Reagents/Consumables Intent to sole source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Great Lakes Acquisition Center, intends to negotiate a sole source contract with BioMerieux, Inc. for the provision of proprietary reagents and consumables necessary for PCR testing on government-owned devices across facilities in Wisconsin, Illinois, and Michigan. This procurement is essential to ensure that the VA can maintain high-quality healthcare services, as only BioMerieux is deemed capable of meeting the specialized requirements for these supplies. The contract will be established as a Blanket Purchase Agreement (BPA) under an existing contract, categorized as firm fixed price, and is being conducted in accordance with FAR 8.405-6. Interested firms must submit their qualifications and relevant customer references to the Contracting Officer, Teresa Beers, at teresa.beers@va.gov within seven calendar days from the publication date of this notice, as no competitive proposals will be solicited.
    Immunohistochemistry (IHC) Platform
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is soliciting quotations for an Immunohistochemistry (IHC) Slide Staining Platform and related supplies for the Madigan Army Medical Center (MAMC) in Tacoma, WA. The procurement aims to acquire an automated Roche/Ventana Benchmark Ultra IHC platform along with necessary antibody stains and reagents to support the Anatomic Pathology mission, with a contract value of $216,810 for a period from October 1, 2024, to June 30, 2025. This initiative is critical for enhancing laboratory capabilities while ensuring compliance with regulatory standards, including FDA approval for all products. Interested offerors must submit their proposals by September 20, 2024, and can direct inquiries to Matthew Kohler at matthew.e.kohler2.civ@health.mil or George Rutt at george.r.rutt.civ@health.mil.
    Laboratory Diagnostic Services
    Active
    Dept Of Defense
    The Department of Defense, specifically the Massachusetts Army National Guard (MA ARNG), is seeking qualified vendors to provide laboratory diagnostic services for its personnel from September 30, 2024, to September 29, 2025. The contractor will be responsible for delivering comprehensive blood and urine laboratory services, including staffing, equipment, and adherence to strict quality control measures, ensuring timely collection, transportation, and testing of samples. These services are crucial for maintaining the health readiness of soldiers, as they must meet specific medical requirements for duty. Interested small businesses must submit their quotes via email by the specified deadline, and further inquiries can be directed to Lacy Phongsaly at lacy.r.phongsaly.civ@army.mil or Lars Bernard at jeffrey.l.bernard6.civ@army.mil. The solicitation number for this opportunity is W912SV-24-Q-0024.
    6640--BD MAX REAGENTS STL
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide molecular testing and extraction supplies for the BD MAX instrument at the St. Louis VA Medical Center. This procurement involves a Firm Fixed Price Blanket Purchase Agreement (BPA) for specific reagents necessary for nucleic acid detection and extraction, with an estimated contract duration of one base year and four optional yearly ordering periods, commencing from November 1, 2024, to October 31, 2029. The supplies are critical for ensuring uninterrupted patient care operations, and interested parties, particularly Service-Disabled Veteran Owned Small Businesses, must submit their responses by September 20, 2024, to Contract Specialist Michael P. Murphy at michael.murphy7@va.gov. The government does not guarantee any contract awards based on this notice, which serves solely for market research purposes.
    Luminex 200
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Submarine Medical Research Laboratory (NSMRL), is seeking proposals for the procurement of a Luminex 200 Instrument System, which is essential for conducting antibody and RNA transcript analyses. This advanced analytical equipment will enable NSMRL to perform in-house biochemical analyses, facilitating the simultaneous detection of multiple proteins and gene expression, thereby improving the health and performance of Navy divers and submariners by addressing risks associated with oxygen toxicity and decompression stress. Interested contractors must submit their proposals by 8:00 AM on September 20, 2024, including detailed pricing and compliance with federal regulations, with a total funding amount of $63,000 for this sole source procurement from Thermofisher Scientific. For further inquiries, interested parties should contact Jessica Lindner at jessica.c.lindner2.civ@us.navy.mil.